MicroRNA-33a inhibits lung cancer cell proliferation and invasion by regulating the expression of β-catenin

Molecular Medicine Reports

Volumn 11, Issue 5, 2015, Pages 3647-3651

  Zhu, Changliang ^a   Zhao, Yachao ^b   Zhang, Zhipei ^a   Ni, Yunfeng ^a   Li, Xiaofei ^a   Yong, Han ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

Lung cancer; MicroRNA 33a; Proliferation; catenin

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 33A; UNCLASSIFIED DRUG; MIRN33 MICRORNA, HUMAN;

A549 CELL LINE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CANCER; PROTEIN EXPRESSION; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; RNA INTERFERENCE; TRANSFECTION;

EID: 84922271795     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3134     Document Type: Article

References (32)

1. Pendharkar D, Ausekar BV and Gupta S: Molecular biology of lung cancer-A review (Review). Indian J Surg Oncol 4: 120-124, 2013.
2. Xue X, Liu Y, Pan L, et al: Diagnosis of multiple primary lung cancer: a systematic review (Review). J Int Med Res 41: 1779-1787, 2013.
3. Blackhall FH, Shepherd FA and Albain KS: Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer: a realistic goal? (Review). Treat Respir Med 4: 71-84, 2005.
4. Cortés-Funes H: New treatment approaches for lung cancer and impact on survival (Review). Semin Oncol 29 (Suppl 8): 26-29, 2002.
5. Wang XC, Tian LL, Jiang XY, et al: The expression and function of miRNA-451 in non-small cell lung cancer. Cancer Lett 311: 203-209, 2011.
6. Chen Z, Zeng H, Guo Y, et al: miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res 29: 151, 2010.
7. Li J, Yang H, Li Y, et al: microRNA-146 up-regulation predicts the prognosis of non-small cell lung cancer by miRNA in situ hybridization. Exp Mol Pathol 96: 195-199, 2014.
8. Salim H, Arvanitis A, de Petris L, et al: miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression. Genes Chromosomes Cancer 52: 895-911, 2013.
9. Iorio MV and Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review (Review). EMBO Mol Med 4: 143-159, 2012.
10. Li YJ, Li ZY and Xu KL: MicroRNA as potential target for genetherapy of multiple myeloma-review (Review). Zhongguo Shi Yan Xue Ye Xue Za Zhi 21: 1318-1325, 2013.
11. Piva R, Spandidos DA and Gambari R: From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review). Int J Oncol 43: 985-994, 2013.
12. An J, Zhu X, Wang H and Jin X: A dynamic interplay between alternative polyadenylation and microRNA regulation: implications for cancer (Review). Int J Oncol 43: 995-1001, 2013.
13. Wijesekara N, Zhang LH, Kang MH, et al: miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes 61: 653-658, 2012.
14. Gharipour M and Sadeghi M: Pivotal role of microRNA-33 in metabolic syndrome: A systematic review (Review). ARYA Atheroscler 9: 372-376, 2013.
15. Cirera-Salinas D, Pauta M, Allen RM, et al: Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 11: 922-933, 2012.
16. Bernas T and Dobrucki J: Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry 47: 236-242, 2002.
17. Sylvester PW: Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Methods Mol Biol 716: 157-168, 2011.
18. Campling BG, Pym J, Baker HM, Cole SP and Lam YM: Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer 63: 75-83, 1991.
19. Nishitani H, Sugimoto N, Roukos V, et al: Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J 25: 1126-1136, 2006.
20. Peng L, Xu Z, Zhou Y, Yang T, Liang ZQ and Zhang M: Effect of rosiglitazone on cells cycle, apoptosis and expression of Skp2 and p27Kip1 in hepatocellular carcinoma cell line. Zhonghua Gan Zang Bing Za Zhi 18: 148-149, 2010 (In Chinese).
21. Schulman BA, Carrano AC, Jeffrey PD, et al: Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408: 381-386, 2000.
22. Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188-193, 1975.
23. Buchegger F, Dupertuis YM and Perillo-Adamer F: A pitfall of propidium iodide staining in fluorescence-activated cell sorting cell cycle analysis? Cancer Res 67: 5576-5577, 2007.
24. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
25. Hu Z, Chen J, Tian T, et al: Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608, 2008.
26. Ohdaira H, Sekiguchi M, Miyata K and Yoshida K: MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif 45: 32-38, 2012.
27. Zhao G, Guo W, Zhao X, Wang Y and Hou Y: Glossy ganoderma spore oil promotes apoptosis of human lung adenocarcinoma SPC-A1 through downregulation of miR-21. Zhongguo Zhong Yao Za Zhi 36: 1231-1234, 2011 (In Chinese).
28. Skrzypek K, Tertil M, Golda S, et al: Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal 19: 644-660, 2013.
29. Nonaka M, Kataoka D, Yamamoto S, et al: Outcome following surgery for primary lung cancer with interlobar pleural invasion. Surg Today 35: 22-27, 2005.
30. Hsu YL, Wu CY, Hung JY, Lin YS, Huang MS and Kuo PL: Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway. Carcinogenesis 34: 1370-1381, 2013.
31. Ding J, Ge D, Guo W and Lu C: Diazoxide-mediated growth inhibition in human lung cancer cells via downregulation of beta-catenin-mediated cyclin D1 transcription. Lung 187: 61-67, 2009.
32. Xiong F, Jiang M, Huang Z, et al: A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Integr Cancer Ther 13: 152-160, 2014